APA (7th ed.) Citation

Saruta, M., Danese, S., Takatori, Y., Kaise, T., Rudolph, C., Ferrante, M., & Hibi, T. (2026). Ulcerative colitis disease severity affects the speed of symptom relief under filgotinib treatment: A post hoc analysis of the phase 2b/3 SELECTION study. Intestinal Research, 24(2), 329. https://doi.org/10.5217/ir.2024.00169

Chicago Style (17th ed.) Citation

Saruta, Masayuki, Silvio Danese, Yoshie Takatori, Toshihiko Kaise, Christine Rudolph, Marc Ferrante, and Toshifumi Hibi. "Ulcerative Colitis Disease Severity Affects the Speed of Symptom Relief Under Filgotinib Treatment: A Post Hoc Analysis of the Phase 2b/3 SELECTION Study." Intestinal Research 24, no. 2 (2026): 329. https://doi.org/10.5217/ir.2024.00169.

MLA (9th ed.) Citation

Saruta, Masayuki, et al. "Ulcerative Colitis Disease Severity Affects the Speed of Symptom Relief Under Filgotinib Treatment: A Post Hoc Analysis of the Phase 2b/3 SELECTION Study." Intestinal Research, vol. 24, no. 2, 2026, p. 329, https://doi.org/10.5217/ir.2024.00169.